Comments
UK cost agency rejects Roche's new melanoma pill
15.06.2012. | LONDON (Reuters) - Swiss group Roche's new melanoma drug Zelboraf has been rejected in a preliminary ruling by Britain's healthcare cost agency, triggering a fresh clash between the world's biggest maker of cancer drugs and NICE....
